Glycemic control in communitydwelling patients with type 2 diabetes

Canadian Pharmacists Journal

Volumn 145, Issue 2, 2012, Pages

  Al Hamarneh, Yazid N ^a   Rosenthal, Meagen ^a   Tsuyuki, Ross T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; BODY MASS; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACY;

EID: 84858611983     PISSN: 17151635     EISSN: 1913701X     Source Type: Journal    
DOI: 10.3821/145.2.cpj68     Document Type: Article

References (12)

1. Canadian Diabetes Association. The harsh reality-diabetes is a global pandemic, 2010. Available: www.diabetes.ca/diabetes-awareness-month/harsh-reality-of-diabetes/(accessed May, 2011).
2. Harris SB, Ekoé JM, Zdanowicz Y, Webster-Bogaert S. Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). Diabetes Res Clin Pract 2005;70:90-97.
3. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011. Available: www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf (accessed June 2011)
4. Canadian Diabetes Association 2008 Clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008;32(suppl 1):S1-S201.
5. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med 2002;162:1149-1155.
6. McLean DL, McAlister FA, Johnson JA, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN). Arch Intern Med 2008;168:2355-2361.
7. Martinez Pérez SR, Armando PD, Molina Guerra AC, et al. Relationship between cardiovascular risk factors and high blood pressure by community pharmacists in Spain. Pharm World Sci 2009;31:406-412.
8. Shiu JR, Simpson SH, Johnson JA, et al. Quantifying opportunities to affect diabetes management in the community. Can Pharm J 2006;139:37-38.
9. Canadian Pharmacists Association. CPhA position statement on pharmacist prescribing, 2007. Available: www.pharmacists.ca/content/about_cpha/who_we_are/policy_position/pdf/CPhA%20position%20statement%20Pharmacist%20Prescribing%20Final2%20August%2007.pdf (accessed June 2011).
10. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy 2008;28:421-436.
11. Gerstein HC, Yale JF, Harris SB, et al. A randomized trial of adding insulin glargine vs. avoidance of insulin in people with type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT study. Diabet Med 2006;23:736-742.
12. Law MR, Ma T, Fisher J, et al. Independent pharmacist prescribing in Canada. Can Pharm J 2012;145:17-23.